Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-01-27

FDA Approved: PILOCARPINE HYDROCHLORIDE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for pilocarpine hydrochloride (Sandoz Inc) to update its labeling with additional indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pilocarpine hydrochloride (Pilocarpine hydrochloride)

Snippet

SUPPL AP for PILOCARPINE HYDROCHLORIDE (PILOCARPINE HYDROCHLORIDE)